DrugPatentWatch Database Preview
ELYXYB Drug Profile
» See Plans and Pricing
Which patents cover Elyxyb, and what generic alternatives are available?
Elyxyb is a drug marketed by Dr Reddys and is included in one NDA. There are four patents protecting this drug.
This drug has sixteen patent family members in twelve countries.
The generic ingredient in ELYXYB is celecoxib. There are twenty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
US ANDA Litigation and Generic Entry Outlook for Elyxyb
A generic version of ELYXYB was approved as celecoxib by MYLAN on May 30th, 2014.
Summary for ELYXYB
| International Patents: | 16 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ELYXYB at DailyMed |
US Patents and Regulatory Information for ELYXYB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Dr Reddys | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Dr Reddys | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Dr Reddys | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Dr Reddys | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ELYXYB
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2708254 | Start Trial |
| China | 107847437 | Start Trial |
| Australia | 2016267685 | Start Trial |
| Japan | 2018516266 | Start Trial |
| Japan | 6605047 | Start Trial |
| European Patent Office | 3302429 | Start Trial |
| South Korea | 20180012277 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ELYXYB
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0731795 | 10075033 | Germany | Start Trial | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
